The use of unique device identifiers is intended to improve patient safety by allowing FDA regulators to track devices on a unit level and recall defective products more easily.
The UDIs will be phased in over the next seven years, beginning with high-risk devices like pacemakers and artificial joints.
More Articles on FDA Regulation:
Michigan Bill Calls for FDA Regulation of Medical Apps
The Case for Integrated Clinical Decision Support Software in EMRs
FDA: How to Use Radio-Frequency Wireless Healthcare Devices
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
